Account Info
Log Out
English
Back
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh Refresh
Loading
History record delete
    Quotes All >
      News All >
        Log in to access Online Inquiry
        Watchlist
        Loading...
        US Stock MarketDetailed Quotes
        MRNS Marinus Pharmaceuticals Watchlist
        7.390 +0.170+2.35% Close 06/02 16:00 ET
        7.3900.0000.00% Post 16:01 ET
        7.520High7.145Low633.73KVolume
        Post-Market
        • 5D
        • 1D
        • 1W
        • 1M
        • 1Q
        • 1Y

        Company

        Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded in August 2003 and is headquartered in Radnor, PA.

        Revenue Breakdown

        Business Unit:USD
        NameYOYOperating income%
        Single Segment--25.48M100.00%

        Comments

        Read more
        Paper Trade Start
        Symbol
        Direction
        Buy
        Sell
        Types
        LMT Order
        Price
        QTY
        Amount
        --